Search

everythinglearnresearchcommunity

for

Search:↓

Corticosteroid pulse therapy is more effective for severe alopecia areata than combination therapy.

Experts created guidelines for who in Australia can get subsidized JAK inhibitor therapy for alopecia areata.

Eating disorders can cause various hair problems, and while hair loss in these disorders is linked to metabolic syndrome, treatment focuses on specific medications and lifestyle changes for the syndrome.

The guideline provides recommendations for managing alopecia areata effectively.

Intralesional steroids can help regrow hair in some alopecia areata patients but have side effects.

Oleic acid nanovesicles improve minoxidil absorption in hair follicles for alopecia treatment.

Botulinum A toxin injections reduced pain and promoted hair regrowth in a woman with a rare form of alopecia areata.

Blood metabolites significantly influence alopecia areata risk.

The document concludes that hair loss and acne in women can be due to both androgen-related and unrelated causes, requiring a collaborative treatment approach.

Etrasimod is safe but not effective for severe alopecia areata, though it may help milder cases.

Alopecia areata and vitiligo share immune system dysfunction but differ in specific immune responses and affected areas.

The mTOR signaling pathway is crucial for hair health and targeting it may lead to new hair loss treatments.

Ritlecitinib may cause severe musculoskeletal pain in some alopecia universalis patients.

Hair transplants can temporarily help with eyebrow hair loss.

Tofacitinib shows promise for treating alopecia areata with significant hair regrowth and mild side effects.

Hair loss can be caused by cancer, treatments, or skin conditions, and trichoscopy helps diagnose it.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

Alopecia areata is an autoimmune disease with genetic links, treatable with certain medications, and can affect mental health.

Type-2 immunity may influence skin diseases and could be targeted for treatment.

Diphenylcyclopropenone is effective and safe for treating severe alopecia areata in children, with maintenance therapy reducing relapse risk.

The document concludes that understanding nail anatomy is key for diagnosing nail diseases, early signs of nail melanoma may allow for less aggressive treatment, and specific genetic mutations are important in thyroid cancer prognosis and treatment.

Different hair diseases affect people during childbearing years, with treatments ranging from medication to psychological support.

Many elderly women experience unwanted facial hair and various hair loss conditions, with treatments available for each condition.

Hair ages and thins due to factors like inflammation and stress, and treatments like antioxidants and hormones might improve hair health.

Chinese patients with alopecia areata value JAK inhibitors but worry about side effects and relapse, highlighting the need for education and support.

JAK inhibitors like tofacitinib can effectively treat severe alopecia areata.

DM and AA may share a common cause.

Clobetasol propionate, 0.05%, is more effective and safe for treating childhood alopecia areata than hydrocortisone, 1%.

DPCP is effective for treating severe alopecia areata, but relapse is common.

PRP shows promise for treating mild alopecia areata but needs more research for cicatricial alopecias.